Dovetail Genomics has started offering a de novo whole genome assembly service. The service, which is underpinned by software that helps to capture long-range genomic data, is intended to complement rather than compete with Illumina ($ILMN). 10X Genomics is following a similar model, but Dovetail CEO Todd Dickinson thinks they are addressing different markets. "For many people who don't have the capital equipment budgets for PacBio [or] 10X, this is a really nice option," he told Bio-IT World. Article